CARM Insider Trading Activity and SEC Form 4 Filings
CARM insider trading summary
No open-market insider purchases or sales of Carisma Therapeutics Inc. (CARM) have been reported on SEC Form 4 in the past 12 months.
Latest CARM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 7, 2025 | Michael Klichinsky | Chief Scientific Officer | Sell | $14K (56,982 @ $0.25) |
| Oct 3, 2025 | Michael Klichinsky | Chief Scientific Officer | Sell | $31K (119,347 @ $0.26) |
| Oct 2, 2025 | Michael Klichinsky | Chief Scientific Officer | Sell | $51K (200,000 @ $0.25) |
| Oct 1, 2025 | Michael Klichinsky | Chief Scientific Officer | Sell | $42K (165,000 @ $0.26) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.